Identification of Pretreatment Agents to Enhance Adenovirus Infection of Bladder Epithelium

作者: Nagarajan Ramesh , Bahram Memarzadeh , Ying Ge , David Frey , Melinda VanRoey

DOI: 10.1016/J.YMTHE.2004.07.002

关键词:

摘要: Abstract Adenovirus has been used widely as a gene transfer vector in the laboratory and clinic for purpose of therapy. Conditionally replication-competent oncolytic adenoviruses are capable multiplying up to thousand old target cells, property that might prove be tremendous potential area cancer Intravesicular therapy refractory superficial bladder employing an adenovirus would allow local administration efficient delivery virus tumor. The glycosaminoglycan layer on surface urothelium acts nonspecific antiadherence barrier may significant roadblock infection by adenoviruses. Several laboratories have investigated utility pretreatment with chemical agents enhance but limited success. A class compounds identified is effective urothelium, permitting adenoviral infection. In murine model, 0.1% dodecyl-β- d -maltoside (DDM) or sodium dodecyl sulfate (SDS) 5 min resulted >90% transduction urothelial within 15 after exposure replication-defective compared ≤5% untreated bladders. DDM could coformulated adenovirus, complete was achieved following retention admixture 45 min. similar enhancement SDS observed rat model. use these facilitate development adenovirus-based cancer.

参考文章(31)
C. L. Parsons, J. D. Lilly, Bladder surface glycosaminoglycans is a human epithelial permeability barrier. Surgery gynecology & obstetrics. ,vol. 171, pp. 493- 496 ,(1990)
L. Parsons, D. Boychuk, S. Jones, R. Hurst, H. Callahan, Bladder Surface Glycosaminoglycans: An Epithelial Permeability Barrier Journal of Urology. ,vol. 143, pp. 139- 142 ,(1990) , 10.1016/S0022-5347(17)39897-X
Jane Zhang, Nagarajan Ramesh, Yu Chen, Yuanhao Li, Jeanette Dilley, Peter Working, De-Chao Yu, Identification of Human Uroplakin II Promoter and Its Use in the Construction of CG8840, a Urothelium-specific Adenovirus Variant That Eliminates Established Bladder Tumors in Combination with Docetaxel Cancer Research. ,vol. 62, pp. 3743- 3750 ,(2002)
John P. Lavelle, Gerard Apodaca, Susan A. Meyers, Wily G. Ruiz, Mark L. Zeidel, Disruption of guinea pig urinary bladder permeability barrier in noninfectious cystitis. American Journal of Physiology-renal Physiology. ,vol. 274, ,(1998) , 10.1152/AJPRENAL.1998.274.1.F205
Motoyuki Yamashita, Charles J Rosser, Jain-Hua Zhou, Xin-Qiao Zhang, Robert J Connor, Heidrun Engler, Daniel C Maneval, Takashi Karashima, Bogdan A Czerniak, Colin P N Dinney, William F Benedict, Syn3 provides high levels of intravesical adenoviral-mediated gene transfer for gene therapy of genetically altered urothelium and superficial bladder cancer Cancer Gene Therapy. ,vol. 9, pp. 687- 691 ,(2002) , 10.1038/SJ.CGT.7700488
Waleed Hassen, Michael J. Droller, Current concepts in assessment and treatment of bladder cancer. Current Opinion in Urology. ,vol. 10, pp. 291- 299 ,(2000) , 10.1097/00042307-200007000-00002
Takao Honda, Hiroshi Saitoh, Masayoshi Masuko, Takako Katagiri-Abe, Kei Tominaga, Ikuo Kozakai, Kazuo Kobayashi, Toshiro Kumanishi, Yuichi G Watanabe, Shoji Odani, Ryozo Kuwano, The coxsackievirus-adenovirus receptor protein as a cell adhesion molecule in the developing mouse brain Molecular Brain Research. ,vol. 77, pp. 19- 28 ,(2000) , 10.1016/S0169-328X(00)00036-X
C. J. Cohen, J. T. C. Shieh, R. J. Pickles, T. Okegawa, J.-T. Hsieh, J. M. Bergelson, The coxsackievirus and adenovirus receptor is a transmembrane component of the tight junction. Proceedings of the National Academy of Sciences of the United States of America. ,vol. 98, pp. 15191- 15196 ,(2001) , 10.1073/PNAS.261452898